Expert Ratings For Molina Healthcare
Portfolio Pulse from Benzinga Insights
Molina Healthcare (NYSE:MOH) has been analyzed by 13 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $368.69, down 3.46% from the previous $381.92. Analysts have adjusted their ratings and price targets in response to market conditions. Molina Healthcare has shown a positive revenue growth rate of 18.65% as of June 2024, but faces challenges with a net margin of 3.05%. The company has a strong ROE of 6.45% and a conservative debt-to-equity ratio of 0.49.

September 10, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Molina Healthcare has received mixed analyst ratings with a current average price target of $368.69, which is a decrease from the previous target. The company has shown strong revenue growth but faces profitability challenges. Analysts have adjusted their ratings and price targets, reflecting varied expectations.
The mixed analyst ratings and the decrease in the average price target suggest a neutral short-term impact on Molina Healthcare's stock price. The company's strong revenue growth is a positive indicator, but the challenges in profitability and the varied analyst expectations balance the outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100